Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T
i
Other names:
CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
SZGIMI
Drug class:
CD123-targeted CAR-T immunotherapy, CD33-targeted CAR-T immunotherapy, CD38-targeted CAR-T immunotherapy, CLL-1-targeted CAR-T immunotherapy
Related drugs:
‹
UCART123 (2)
ACLX-002 (1)
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR (0)
4SCAR-T (0)
AVC-101 (0)
AVC-201 (0)
Autologous CAR-T cells (0)
CART123 (0)
CD123 CAR-T cell therapy (0)
CD123-CAR T cell therapy (0)
EQ (0)
CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells (0)
IM23 (0)
MB-102 (0)
Muc1/CLL1/CD33/CD38/CD56/CD123-specific gene-engineered T cells (0)
SENL401 (0)
anti-CD123 CAR-T (0)
CART-33 (0)
CART-33 (0)
CD33 CAR T cells (0)
CD33 CAR-T (0)
CD33 CAR-T (0)
CD33PAN CAR T (0)
CLL1+CD33 CAR-T (0)
DARIC33 (0)
Dual CD33/CLL1 CAR T (0)
ICG165 (0)
PRGN-3006 (0)
VCAR33ALLO (0)
anti-CD33 CAR T (0)
multi-target gene-modified CAR-T/TCR-T cell immunotherapy (0)
CART-38 (0)
CART-38 (0)
CB-012 (0)
CD371-YSNVZ-IL18 CAR T cells (0)
KITE-222 (0)
UCART123 (2)
ACLX-002 (1)
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR (0)
4SCAR-T (0)
AVC-101 (0)
AVC-201 (0)
Autologous CAR-T cells (0)
CART123 (0)
CD123 CAR-T cell therapy (0)
CD123-CAR T cell therapy (0)
EQ (0)
CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells (0)
IM23 (0)
MB-102 (0)
Muc1/CLL1/CD33/CD38/CD56/CD123-specific gene-engineered T cells (0)
SENL401 (0)
anti-CD123 CAR-T (0)
CART-33 (0)
CART-33 (0)
CD33 CAR T cells (0)
CD33 CAR-T (0)
CD33 CAR-T (0)
CD33PAN CAR T (0)
CLL1+CD33 CAR-T (0)
DARIC33 (0)
Dual CD33/CLL1 CAR T (0)
ICG165 (0)
PRGN-3006 (0)
VCAR33ALLO (0)
anti-CD33 CAR T (0)
multi-target gene-modified CAR-T/TCR-T cell immunotherapy (0)
CART-38 (0)
CART-38 (0)
CB-012 (0)
CD371-YSNVZ-IL18 CAR T cells (0)
KITE-222 (0)
›
Associations
News
Trials
Filter by
Latest
over1year
Universal CAR-T Cells Targeting AML (clinicaltrials.gov)
P1, N=30, Recruiting, Shenzhen Geno-Immune Medical Institute
over 1 year ago
New P1 trial • CAR T-Cell Therapy
|
CD38 (CD38 Molecule) • CD33 (CD33 Molecule) • IL3RA (Interleukin 3 Receptor Subunit Alpha)
|
CD123 expression
|
CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login